Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-010304
Filing Date
2024-09-12
Accepted
2024-09-12 11:36:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29302
2 filename2.txt TEXT-EXTRACT 2854
  Complete submission text file 0000000000-24-010304.txt   44144
Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Filed for) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-39263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)